학술논문
VP3-2024: A randomized study of 6 vs 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse
Document Type
Abstract
Author
Source
In Annals of Oncology June 2024 35(6):576-577
Subject
Language
ISSN
0923-7534